Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BLBD vs DORM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BLBD
Blue Bird Corporation

Auto - Manufacturers

Consumer CyclicalNASDAQ • US
Market Cap$2.24B
5Y Perf.+393.7%
DORM
Dorman Products, Inc.

Auto - Parts

Consumer CyclicalNASDAQ • US
Market Cap$3.72B
5Y Perf.+78.1%

BLBD vs DORM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BLBD logoBLBD
DORM logoDORM
IndustryAuto - ManufacturersAuto - Parts
Market Cap$2.24B$3.72B
Revenue (TTM)$1.49B$2.15B
Net Income (TTM)$133M$190M
Gross Margin21.0%40.7%
Operating Margin11.9%15.6%
Forward P/E15.6x15.0x
Total Debt$90M$633M
Cash & Equiv.$229M$49M

BLBD vs DORMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BLBD
DORM
StockMay 20May 26Return
Blue Bird Corporati… (BLBD)100493.7+393.7%
Dorman Products, In… (DORM)100178.1+78.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: BLBD vs DORM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BLBD leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Dorman Products, Inc. is the stronger pick specifically for capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
BLBD
Blue Bird Corporation
The Growth Play

BLBD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 9.9%, EPS growth 22.8%, 3Y rev CAGR 22.7%
  • 5.6% 10Y total return vs DORM's 129.7%
  • PEG 0.24 vs DORM's 1.00
Best for: growth exposure and long-term compounding
DORM
Dorman Products, Inc.
The Income Pick

DORM is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 2 yrs, beta 0.85
  • Lower volatility, beta 0.85, Low D/E 42.9%, current ratio 3.09x
  • Beta 0.85, current ratio 3.09x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthBLBD logoBLBD9.9% revenue growth vs DORM's 6.0%
ValueBLBD logoBLBDPEG 0.24 vs 1.00
Quality / MarginsBLBD logoBLBD8.9% margin vs DORM's 8.8%
Stability / SafetyDORM logoDORMBeta 0.85 vs BLBD's 1.15
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BLBD logoBLBD+87.7% vs DORM's +0.5%
Efficiency (ROA)BLBD logoBLBD21.0% ROA vs DORM's 7.6%, ROIC 102.6% vs 13.9%

BLBD vs DORM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BLBDBlue Bird Corporation
FY 2025
Alternative Fuel Buses
53.9%$798M
Diesel Buses
35.4%$523M
Parts
6.8%$100M
Product and Service, Other
3.9%$58M
DORMDorman Products, Inc.
FY 2022
Chassis
50.4%$715M
Powertrain
45.4%$644M
Hardware
4.2%$60M

BLBD vs DORM — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBLBDLAGGINGDORM

Income & Cash Flow (Last 12 Months)

Evenly matched — BLBD and DORM each lead in 3 of 6 comparable metrics.

DORM and BLBD operate at a comparable scale, with $2.2B and $1.5B in trailing revenue. Profitability is closely matched — net margins range from 8.9% (BLBD) to 8.8% (DORM). On growth, DORM holds the edge at +4.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
RevenueTrailing 12 months$1.5B$2.2B
EBITDAEarnings before interest/tax$185M$377M
Net IncomeAfter-tax profit$133M$190M
Free Cash FlowCash after capex$197M$71M
Gross MarginGross profit ÷ Revenue+21.0%+40.7%
Operating MarginEBIT ÷ Revenue+11.9%+15.6%
Net MarginNet income ÷ Revenue+8.9%+8.8%
FCF MarginFCF ÷ Revenue+13.2%+3.3%
Rev. Growth (YoY)Latest quarter vs prior year-1.7%+4.2%
EPS Growth (YoY)Latest quarter vs prior year+13.9%-23.5%
Evenly matched — BLBD and DORM each lead in 3 of 6 comparable metrics.

Valuation Metrics

BLBD leads this category, winning 4 of 7 comparable metrics.

At 18.3x trailing earnings, BLBD trades at a 3% valuation discount to DORM's 18.8x P/E. Adjusting for growth (PEG ratio), BLBD offers better value at 0.29x vs DORM's 1.25x — a lower PEG means you pay less per unit of expected earnings growth.

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
Market CapShares × price$2.2B$3.7B
Enterprise ValueMkt cap + debt − cash$2.1B$4.3B
Trailing P/EPrice ÷ TTM EPS18.26x18.75x
Forward P/EPrice ÷ next-FY EPS est.15.59x15.05x
PEG RatioP/E ÷ EPS growth rate0.29x1.25x
EV / EBITDAEnterprise value multiple11.49x10.41x
Price / SalesMarket cap ÷ Revenue1.51x1.75x
Price / BookPrice ÷ Book value/share9.12x2.59x
Price / FCFMarket cap ÷ FCF14.59x49.18x
BLBD leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

BLBD leads this category, winning 8 of 8 comparable metrics.

BLBD delivers a 50.8% return on equity — every $100 of shareholder capital generates $51 in annual profit, vs $13 for DORM. BLBD carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to DORM's 0.43x.

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
ROE (TTM)Return on equity+50.8%+13.1%
ROA (TTM)Return on assets+21.0%+7.6%
ROICReturn on invested capital+102.6%+13.9%
ROCEReturn on capital employed+49.4%+18.5%
Piotroski ScoreFundamental quality 0–977
Debt / EquityFinancial leverage0.35x0.43x
Net DebtTotal debt minus cash-$139M$584M
Cash & Equiv.Liquid assets$229M$49M
Total DebtShort + long-term debt$90M$633M
Interest CoverageEBIT ÷ Interest expense394.69x8.24x
BLBD leads this category, winning 8 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

BLBD leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in BLBD five years ago would be worth $26,732 today (with dividends reinvested), compared to $11,922 for DORM. Over the past 12 months, BLBD leads with a +87.7% total return vs DORM's +0.5%. The 3-year compound annual growth rate (CAGR) favors BLBD at 53.1% vs DORM's 12.3% — a key indicator of consistent wealth creation.

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
YTD ReturnYear-to-date+51.5%+0.3%
1-Year ReturnPast 12 months+87.7%+0.5%
3-Year ReturnCumulative with dividends+258.7%+41.6%
5-Year ReturnCumulative with dividends+167.3%+19.2%
10-Year ReturnCumulative with dividends+557.8%+129.7%
CAGR (3Y)Annualised 3-year return+53.1%+12.3%
BLBD leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BLBD and DORM each lead in 1 of 2 comparable metrics.

DORM is the less volatile stock with a 0.85 beta — it tends to amplify market swings less than BLBD's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BLBD currently trades 86.9% from its 52-week high vs DORM's 74.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
Beta (5Y)Sensitivity to S&P 5001.15x0.85x
52-Week HighHighest price in past year$81.51$166.89
52-Week LowLowest price in past year$36.01$98.44
% of 52W HighCurrent price vs 52-week peak+86.9%+74.6%
RSI (14)Momentum oscillator 0–10060.071.2
Avg Volume (50D)Average daily shares traded357K273K
Evenly matched — BLBD and DORM each lead in 1 of 2 comparable metrics.

Analyst Outlook

DORM leads this category, winning 1 of 1 comparable metric.

Wall Street rates BLBD as "Buy" and DORM as "Buy". Consensus price targets imply 12.4% upside for DORM (target: $140) vs -1.7% for BLBD (target: $70).

MetricBLBD logoBLBDBlue Bird Corpora…DORM logoDORMDorman Products, …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$69.67$140.00
# AnalystsCovering analysts1216
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises02
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+2.2%+1.1%
DORM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

BLBD leads in 3 of 6 categories (Valuation Metrics, Profitability & Efficiency). DORM leads in 1 (Analyst Outlook). 2 tied.

Best OverallBlue Bird Corporation (BLBD)Leads 3 of 6 categories
Loading custom metrics...

BLBD vs DORM: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is BLBD or DORM a better buy right now?

For growth investors, Blue Bird Corporation (BLBD) is the stronger pick with 9.

9% revenue growth year-over-year, versus 6. 0% for Dorman Products, Inc. (DORM). Blue Bird Corporation (BLBD) offers the better valuation at 18. 3x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Blue Bird Corporation (BLBD) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BLBD or DORM?

On trailing P/E, Blue Bird Corporation (BLBD) is the cheapest at 18.

3x versus Dorman Products, Inc. at 18. 8x. On forward P/E, Dorman Products, Inc. is actually cheaper at 15. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Blue Bird Corporation wins at 0. 24x versus Dorman Products, Inc. 's 1. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — BLBD or DORM?

Over the past 5 years, Blue Bird Corporation (BLBD) delivered a total return of +167.

3%, compared to +19. 2% for Dorman Products, Inc. (DORM). Over 10 years, the gap is even starker: BLBD returned +557. 8% versus DORM's +129. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BLBD or DORM?

By beta (market sensitivity over 5 years), Dorman Products, Inc.

(DORM) is the lower-risk stock at 0. 85β versus Blue Bird Corporation's 1. 15β — meaning BLBD is approximately 35% more volatile than DORM relative to the S&P 500. On balance sheet safety, Blue Bird Corporation (BLBD) carries a lower debt/equity ratio of 35% versus 43% for Dorman Products, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BLBD or DORM?

By revenue growth (latest reported year), Blue Bird Corporation (BLBD) is pulling ahead at 9.

9% versus 6. 0% for Dorman Products, Inc. (DORM). On earnings-per-share growth, the picture is similar: Blue Bird Corporation grew EPS 22. 8% year-over-year, compared to 8. 1% for Dorman Products, Inc.. Over a 3-year CAGR, BLBD leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BLBD or DORM?

Dorman Products, Inc.

(DORM) is the more profitable company, earning 9. 6% net margin versus 8. 6% for Blue Bird Corporation — meaning it keeps 9. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DORM leads at 16. 8% versus 11. 3% for BLBD. At the gross margin level — before operating expenses — DORM leads at 41. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BLBD or DORM more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Blue Bird Corporation (BLBD) is the more undervalued stock at a PEG of 0. 24x versus Dorman Products, Inc. 's 1. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Dorman Products, Inc. (DORM) trades at 15. 0x forward P/E versus 15. 6x for Blue Bird Corporation — 0. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DORM: 12. 4% to $140. 00.

08

Which pays a better dividend — BLBD or DORM?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is BLBD or DORM better for a retirement portfolio?

For long-horizon retirement investors, Blue Bird Corporation (BLBD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

15), +557. 8% 10Y return). Both have compounded well over 10 years (BLBD: +557. 8%, DORM: +129. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BLBD and DORM?

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BLBD

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

DORM

Quality Business

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BLBD and DORM on the metrics below

Revenue Growth>
%
(BLBD: -1.7% · DORM: 4.2%)
Net Margin>
%
(BLBD: 8.9% · DORM: 8.8%)
P/E Ratio<
x
(BLBD: 18.3x · DORM: 18.8x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.